Tested Applications
| Positive IHC detected in | human gliomas tissue Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0 |
| Positive FC (Intra) detected in | HEK-293 cells |
Recommended dilution
| Application | Dilution |
|---|---|
| Immunohistochemistry (IHC) | IHC : 1:50-1:500 |
| Flow Cytometry (FC) (INTRA) | FC (INTRA) : 0.25 ug per 10^6 cells in a 100 ul suspension |
| It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
| Sample-dependent, Check data in validation data gallery. | |
Product Information
19778-1-AP targets ADRA2B-Specific in WB, IHC, IF, ELISA applications and shows reactivity with human samples.
| Tested Reactivity | human |
| Cited Reactivity | mouse, rat |
| Host / Isotype | Rabbit / IgG |
| Class | Polyclonal |
| Type | Antibody |
| Immunogen |
Peptide Predict reactive species |
| Full Name | adrenergic, alpha-2B-, receptor |
| Calculated Molecular Weight | 50 kDa |
| GenBank Accession Number | NM_000682 |
| Gene Symbol | ADRA2B |
| Gene ID (NCBI) | 151 |
| RRID | AB_10640910 |
| Conjugate | Unconjugated |
| Form | Liquid |
| Purification Method | Antigen affinity purification |
| UNIPROT ID | P18089 |
| Storage Buffer | PBS with 0.02% sodium azide and 50% glycerol, pH 7.3. |
| Storage Conditions | Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA. |
Background Information
ADRA2B, also named as ADRA2L1 and ADRA2RL1, belongs to the G-protein coupled receptor 1 family. ADRA2B mediates the catecholamine-induced inhibition of adenylate cyclase through the action of G proteins. The antibody is specific to ADRA2B.
Protocols
| Product Specific Protocols | |
|---|---|
| FC protocol for ADRA2B-Specific antibody 19778-1-AP | Download protocol |
| IHC protocol for ADRA2B-Specific antibody 19778-1-AP | Download protocol |
| Standard Protocols | |
|---|---|
| Click here to view our Standard Protocols |
Publications
What published studies show
The ADRA2B-Specific Polyclonal antibody (Cat# 19778-1-AP) has 5 citations across Nature Communications, European Journal of Pharmacology, Bone & Joint Research, Cell and Tissue Research, and Journal of Pharmacological Sciences. Research fields span neurodegeneration (tauopathy and adrenergic signaling), acute and chronic kidney injury, sympathetic activation in fracture models, and subcellular distribution of α2-adrenoceptor subtypes in rodent kidney. Applications include WB, IF, and IHC in mouse and rat.
| Species | Application | Title |
|---|---|---|
Nat Commun Chromogranin A deficiency attenuates tauopathy by altering epinephrine-alpha-adrenergic receptor signaling in PS19 mice | ||
Eur J Pharmacol Yohimbine ameliorates lipopolysaccharide-induced acute kidney injury in rats. | ||
Bone Joint Res Transient acute kidney injury following femoral fracture in mice : the role of sympathetic activation. | ||
Cell Tissue Res Subcellular distribution of α2-adrenoceptor subtypes in the rodent kidney. | ||
J Pharmacol Sci Inhibition of α2-adrenoceptor is renoprotective in 5/6 nephrectomy-induced chronic kidney injury rats. |





